Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Contraception and Contraceptive Drugs

  Free Subscription


15.10.2018

1 Gynecol Endocrinol
3 J Clin Endocrinol Metab
1 Obstet Gynecol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Gynecol Endocrinol

  1. XU Z, Meng L, Pan C, Chen X, et al
    Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  2. BARRIONUEVO P, Nabhan M, Altayar O, Wang Z, et al
    Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis.
    J Clin Endocrinol Metab. 2018;103:1258-1264.
    PubMed     Text format     Abstract available

  3. MARTIN KA, Anderson RR, Chang RJ, Ehrmann DA, et al
    Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2018;103:1233-1257.
    PubMed     Text format     Abstract available

  4. COURTOY GE, Henriet P, Marbaix E, de Codt M, et al
    Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment.
    J Clin Endocrinol Metab. 2018 Feb 1. pii: 4834038. doi: 10.1210/jc.2017-02295.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  5. BRANDI K, Morgan JR, Paasche-Orlow MK, Perkins RB, et al
    Obstetric Outcomes After Failed Hysteroscopic and Laparoscopic Sterilization Procedures.
    Obstet Gynecol. 2018 Jan 9. doi: 10.1097/AOG.0000000000002446.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: